combining semaglutide with tirzepatide & Tirzepatide: Can You Combine Them? Switching from Semaglutide to Tirzepatide:

Gastrointestinal and pancreatic history Because GLP-1 medications slow gastric emptying and act on the digestive system, clinicians typically screen for a history of pancreatitis, gallbladder disease, and significant gastrointestinal disorders

Nausea (44%) Most common in weeks 1 to 4 during dose titration

If your clinician agrees to a trial, start with a low dose and recheck labs in four to eight weeks

References American Psychiatric Association

Performing the Aalens additive hazards model on the intention-to-treat analysis revealed a continuing downward slope for GLP-1 RAs and a less pronounced attenuation on intermediate time-scales (slope -0.0038, p = 0.015)